Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 5/20 | 0.95 |
| ▸ | TYR | P14679 | 3/20 | 0.95 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.95 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.95 |
| ▸ | CA12 | O43570 | 3/20 | 0.95 |
| ▸ | CA1 | P00915 | 3/20 | 0.95 |
| ▸ | CA2 | P00918 | 3/20 | 0.95 |
| ▸ | CA7 | P43166 | 3/20 | 0.95 |
| ▸ | CA9 | Q16790 | 3/20 | 0.95 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.95 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.95 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.95 |
| ▸ | PKM | P14618 | 2/20 | 0.95 |
| ▸ | CA3 | P07451 | 2/20 | 0.95 |
| ▸ | CA4 | P22748 | 2/20 | 0.95 |
| ▸ | CA6 | P23280 | 2/20 | 0.95 |
| ▸ | DPP4 | P27487 | 2/20 | 0.95 |
| ▸ | CA5A | P35218 | 2/20 | 0.95 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.95 |
| ▸ | F3 | P13726 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumaric Acid SCHEMBL6328280 | 1.00 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL20702657 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL39106 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL6333102 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL6333097 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL434720 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL43601 | 0.98 | ESR1 (1.00) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL7871865 | 0.95 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL7040450 | 0.95 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 | |
| Coumaric Acid SCHEMBL8377539 | 0.95 | ESR1 (0.95) | ESR1TYRAKR1B10AKR1B1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6876540-B2 | Electrolyte for use in a capacitor | EPCOS AG (DE) | 2005-04-05 | — | — | US | claimed |
| US-20040114308-A1 | Electrolyte for an aluminium-electrolyte capacitor, capacitor which uses the electrolyte and the use of said capacitor | EPCOS AG (DE) | 2004-06-17 | — | — | US | claimed |
| US-10689672-B2 | Vanillin synthase | EVOLVA SA (CH) | 2020-06-23 | — | — | US | disclosed |
| US-20070142472-A1 | Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1687250-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS | Takasago International Corporation (JP) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005051882-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-06-09 | — | — | WO | disclosed |
| US-6876540-B2 | Electrolyte for use in a capacitor | EPCOS AG (DE) | 2005-04-05 | — | — | US | disclosed |
| US-20040114308-A1 | Electrolyte for an aluminium-electrolyte capacitor, capacitor which uses the electrolyte and the use of said capacitor | EPCOS AG (DE) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142472-A1 | Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids | ALDH1A2, ALDH1A3, GRHPR | ESR1 2687/4885TYR 209/4885AKR1B10 143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.